Tiziana Life Sciences Ltd (TLSA)
NASDAQ: TLSA · Real-Time Price · USD
2.380
-0.120 (-4.80%)
At close: Aug 1, 2025, 4:00 PM
2.380
0.00 (0.00%)
After-hours: Aug 1, 2025, 5:56 PM EDT
Accolade Market Cap
Tiziana Life Sciences has a market cap or net worth of $265.28 million as of August 1, 2025. Its market cap has increased by 222.62% in one year.
Market Cap
265.28M
Enterprise Value
261.66M
1-Year Change
222.62%
Ranking
Category
Stock Price
$2.38
Market Cap Chart
Since October 21, 2021, Tiziana Life Sciences's market cap has increased from $145.96M to $265.28M, an increase of 81.75%. That is a compound annual growth rate of 17.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 278.66M | 266.92% |
| Dec 31, 2024 | 75.95M | 34.82% |
| Dec 29, 2023 | 56.33M | -7.14% |
| Dec 30, 2022 | 60.66M | -35.06% |
| Dec 31, 2021 | 93.41M | -36.00% |
| Oct 21, 2021 | 145.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 664.39B |
| Johnson & Johnson | 396.75B |
| AbbVie | 333.89B |
| AstraZeneca | 232.21B |
| UnitedHealth Group | 226.39B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 219.63B |
| Novo Nordisk | 213.92B |